SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

LifeMD, Inc. (LFMD) News

Follow LifeMD, Inc. (LFMD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol LFMD Asset equity Sector Markets 90 days 4 Last 1.44 Updated Nov 13, 2026, 02:07 PM UTC Open live news feed Open LFMD chart & news
M LifeMD Cuts Full-Year 2026 Revenue Guidance to $188M-$191M LifeMD lowered its 2026 revenue forecast from $205.5 million-$212.5 million to $188 million-$191 million. It projected fourth-quarter revenue of $46 million-$49 million. EQUITY | Nov 13, 2026, 02:07 PM UTC M LifeMD Q3 Revenue Misses Estimates; Company Lowers FY Outlook LifeMD reported Q3 revenue below analyst estimates and lowered its full-year outlook. EQUITY | Nov 12, 2026, 09:23 PM UTC L AT&T and LifeMD strike exclusive deal to offer free $228/year virtual care to 100M+ customers LifeMD announced an exclusive collaboration with AT&T to provide eligible AT&T wireless and fiber customers a complimentary LifeMD membership valued at $228 per year.Key Highlights:Original SEC Filing: LifeMD, Inc. [ LFM REGULATION | Sep 15, 2026, 02:24 PM UTC L T LFMD - AT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD T LFMD - AT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD NEWS | Sep 15, 2026, 01:03 PM UTC H LFMD Price Target Cut to $9 at BTIG LFMD price target lowered to $9 EQUITY | Aug 06, 2026, 09:44 AM UTC L LifeMD Lowers FY2026 Sales Guidance from $220.000M-$230.000M to $205.500M-$212.500M vs $222.046M Est LifeMD (NASDAQ: LFMD ) lowers FY2026 sales outlook from $220.000 million-$230.000 million to $205.500 million-$212.500 million vs $222.046 million estimate. EARNINGS | Aug 05, 2026, 08:49 PM UTC M LFMD: Launches Self-Pay Program LifeMD announces exclusive collaboration to launch direct-to-patient self-pay program for XYOSTED injection EQUITY | Jun 22, 2026, 12:02 PM UTC